Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 6:16 AM ET | Feedback | Site Changes | Help
Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.
View All Commentary (CRME)
Recs
cashsage (44.47) Submitted: 7/03/08 5:01 PM : Start Price: $8.65 CRME Score: 10.09
CRME is one of the companies with a too high valuation compared to its sales potential.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK